ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

TRLS Trellus Health Plc

1.65
0.00 (0.00%)
20 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Trellus Health Plc LSE:TRLS London Ordinary Share GB00BNNFM402 ORD GBP0.0006
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1.65 1.50 1.80 1.65 1.65 1.65 0.00 07:40:53
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Offices Of Medical Doctors 19k -6.34M -0.0392 -0.42 2.66M
Trellus Health Plc is listed in the Offices Of Medical Doctors sector of the London Stock Exchange with ticker TRLS. The last closing price for Trellus Health was 1.65p. Over the last year, Trellus Health shares have traded in a share price range of 1.65p to 9.20p.

Trellus Health currently has 161,508,333 shares in issue. The market capitalisation of Trellus Health is £2.66 million. Trellus Health has a price to earnings ratio (PE ratio) of -0.42.

Trellus Health Share Discussion Threads

Showing 1 to 13 of 325 messages
Chat Pages: Latest  1
DateSubjectAuthorDiscuss
26/5/2021
09:08
Good question!
CD

cambridgedon
26/5/2021
08:42
Just a quick question for some of you guys that are with barclays.
I have ekf shares but cannot take up the offer to buy trellis.
Will those I qualify for as aong term holder show up in my account, though restricted, or will I need to contact barclays.
Apologies if a poor question.
Thank you.

aspringo
25/5/2021
11:12
I applied for 20,000 but the ISA (CSD temporary home for the A shares but they will not be able to stay there) shows subscription rights for 200,000, which I think must be CSD typo as there is no basis for allocation.
bscuit
25/5/2021
07:54
Just for the record to save digging back to the announcement

"The expected admission date for Trellus Shares to commence trading on AIM is 8:00 a.m. on Friday, 28 May 2021. Shareholders will be informed their restricted allocation just before trading on Friday, 28 May 2021. "

Surprised that the gap between closing on Monday 24th and Friday for commencement -

pugugly
24/5/2021
17:46
Given the demand indicated i think we will be lucky to get 20%. The alternative is they cap the figure for all applicants notwithstanding what they applied for, say 1500 shares for every applicant (or lower if their application was below this).

I am certainly expecting to be refunded most of my money - we will know soon.

cgequityinvest
24/5/2021
12:59
What are we all expecting as a scale back allocation only had 1000 specie shares
retirementfund
24/5/2021
09:52
With Interactive Investors ISA, I have a number of shares at 40p - not as 60p ( adobbing). I got 2.5 share for every £1 requested. This 'full' allocation is displayed at 0p. I guess it will get scaled back when the real numbers are in on Friday morning. (Quote from RNS - The expected admission date for Trellus Shares to commence trading on AIM is 8:00 a.m. on Friday, 28 May 2021. Shareholders will be informed their restricted allocation just before trading on Friday, 28 May 2021. )
martinikenny
24/5/2021
08:55
Just checked my Interactive Investors ISA and it now shows 2500 Tellus health restricted offer.
Value shows as £0 and price shows as 0p
As I requested £1000 worth, I’m guessing that at 40p I got the full amount I subscribed for.

Updated after checking my account, I must have only gone for £1000 not £1500!

adobbing
22/5/2021
12:14
Adding my thanks Wan (aka Speedy Gonzales)
welshborderer
22/5/2021
09:43
Excellent. Thanks Wan.
Cd

cambridgedon
22/5/2021
07:16
Thanks wan
capitalist
22/5/2021
06:39
Initial Trellus Health thread, I will edit and populate the header further in due course.
wan
22/5/2021
06:34
LONDON, UK. AND NEW YORK, U.S. (20 May 2021). Trellus Health plc (AIM: TRLS), which is commercialising a scientifically validated, resilience-based, connected digital health solution for chronic condition management, is pleased to announce that it is today launching the Restricted Offer element of its Fundraising, having received very strong levels of support for the placing and subscription.

Key Fundraising Statistics:

Total Fundraising Size: £28.5 million

Issue Price per Trellus Share: 40 pence

Number of Ordinary Shares in issue at Admission 161,475,000

Market capitalisation at the Issue Price: circa £64.6 million

Trellus Health - Precision Medicine Meets Resilience-Driven Care
Because everyone living with a chronic condition should have hope and thrive.

Coordinating and Connecting Multidisciplinary Care for Complex Chronic Conditions, Starting with IBD

Trellus coordinates expert whole-person care rooted in resilience for people living with complex chronic conditions, improving outcomes and lowering overall healthcare costs and is transforming the way chronic conditions are treated.


The Company will utilise a team of licensed, multidisciplinary healthcare providers to deliver and coordinate care remotely via telehealth.

Technology platform and intellectual property:
The Company’s connected health solution will be enabled through an integrated suite of technology and IP to enable scalable remote access for the Company’s care team, patients, and their health care providers.

The primary components of the Company’s connected health solution include:
*TrellusElevateTM platform
*HIPAA-Compliant telehealth platform
*GRITTTM resilience assessment and personalised care plans
*Quad4XTM risk stratifier
*Digital education and behavioural tools
*Remote patient monitoring of symptoms, biomarkers, behaviours

The Company expects to generate initial revenue in 2021 through demonstration projects with healthcare payers in the New York City metropolitan area. The Company’s digitally-delivered solution and value-based recurring revenue model will present attractive unit economics, high margins, cash generation, and forward visibility as a function of the number of engaged patients in the program.

Informative interview/Q&A -
Trellus Health IPO - Management Q&A


Healthtech in the fast lane: What is fueling investor excitement?
As adoption of healthcare technology accelerates, it’s a good time for healthcare companies to consider investing in digital among nine potential “value pools.”

wan
Chat Pages: Latest  1

Your Recent History

Delayed Upgrade Clock